<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04603625</url>
  </required_header>
  <id_info>
    <org_study_id>723/2020/SPER/AUSLRE</org_study_id>
    <nct_id>NCT04603625</nct_id>
  </id_info>
  <brief_title>Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy</brief_title>
  <acronym>CPluxprev2020</acronym>
  <official_title>Postural Management to Prevent Hip Luxation in Quadriplegic Cerebral Palsy Children: Comparing Two Approaches in a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Unità Sanitaria Locale Reggio Emilia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale IRCCS G. Gaslini di Genova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Eugenio Medea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Don Carlo Gnocchi di Firenze</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Unita' Sanitaria Locale Di Modena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Usl di Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Unità Sanitaria Locale della Romagna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda ULSS di Verona e Provincia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda Unità Sanitaria Locale Reggio Emilia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral palsy (CP) is the most common motor disability in childhood. Among these, hip&#xD;
      luxation represents the most frequent and clinically relevant one, affecting 72% of&#xD;
      non-ambulatory CP children. Reconstructive surgical treatment is debated in severe CP&#xD;
      children, for whom it is crucial to identify an effective preventive approach. The aim of our&#xD;
      study is to verify if keeping a sitting position centering femoral heads is more effective&#xD;
      than usual postural management (sitting with the trunk aligned and hips abducted), in&#xD;
      preventing hip luxation in quadriplegic CP children. It's a multicenter randomized controlled&#xD;
      study (13 sites involved). A total of 102 quadriplegic CP children, aged 1-6 years-old,&#xD;
      classified as Gross Motor Function Measure System 4 or 5, will be recruited and randomized to&#xD;
      usual or experimental sitting, at least 5 hours a day, for 2 years. The primary outcome will&#xD;
      be the degree of luxation, measured by means of the Migration Percentage (MP), on pelvic&#xD;
      radiography, at 12 and 24 months. Secondary outcomes will include compliance and Health&#xD;
      Related-Quality of Life, using validated tools, hip pain, device cost, MRI lesions,&#xD;
      concurrent direct neuromotor treatment, use of standing devices and spasticity treatments&#xD;
      (botulinum toxin, per os or intrathecal baclofen, selective dorsal rhizotomy). Experimental&#xD;
      sitting is expected to reduce the MP change compared to usual care. It will be of interest to&#xD;
      compare compliance, QoL and costs in either groups: aspects affecting the effectiveness.&#xD;
      Furthermore to evaluate correlations between MP and spasticity treatments, MRI lesion type,&#xD;
      and other clinical features.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Physicians measuring Migration Percentage (Primary Outcome) will be blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Migration Percentage</measure>
    <time_frame>Day 0, Month 12, Months 24</time_frame>
    <description>measure of hip luxation on pelvic radiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Caregiver Priorities &amp; Child Health Index of Life with Disabilities (CPCHILD)</measure>
    <time_frame>Day 0, Month 12, Month 24</time_frame>
    <description>Parents will fill in a questionnaire about Health Related Quality of Life referred to their child. Minimum value 0, maximum value 100, higher scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quebec User Evaluation of Satisfaction with Assistive Technology (IT-QUEST)</measure>
    <time_frame>Month 12, Month 24</time_frame>
    <description>Parents will fill in a questionnaire measuring their satisfaction about the assistive device ensuring the desired sitting position of their child. Minimum value 1, maximum value 5,higher scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of pain</measure>
    <time_frame>Day 0, Month 6, Month 12, Month 18, Month 24</time_frame>
    <description>Care givers will be interviewed about presence or absence of hip pain in the previous months during personal care and activities of daily living</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assistive devices costs</measure>
    <time_frame>Day 0, Month 6, Month 12, Month 18, Month 24</time_frame>
    <description>Costs paid by Health Institution for sitting systems used during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients attending Botulinum Toxin-A injections</measure>
    <time_frame>Day 0, Month 6, Month 12, Month 18, Month 24</time_frame>
    <description>Botulinum Toxin-A injections in muscles around the hip during the study will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients attending direct physical treatment</measure>
    <time_frame>Day 0, Month 6, Month 12, Month 18, Month 24</time_frame>
    <description>Physiotherapy, other Neuromotor Therapy during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients using standing devices in abduction</measure>
    <time_frame>Day 0, Month 6, Month 12, Month 18, Month 24</time_frame>
    <description>It will be recorded if the patients will be using standing devices at least 5 hours/week, less than 5 h/week or never</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of CP (Dyskinetic or spastic)</measure>
    <time_frame>Day 0</time_frame>
    <description>Type of CP will be recorded to evaluate any association with MP change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients having Intrathecal Baclofen (ITB)</measure>
    <time_frame>Day 0</time_frame>
    <description>It will be recorded if patients have ITB to evaluate any association with MP change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients taking Baclofen per os</measure>
    <time_frame>Day 0, Month 6, Month 12, Month 18, Month 24</time_frame>
    <description>Baclofen oral medication during the study will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients who underwent Selective Dorsal Rhizotomy (SDR)</measure>
    <time_frame>Day 0</time_frame>
    <description>It will be recorded if patients underwent SDR in the past to evaluate any association with MP change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>Day 0</time_frame>
    <description>Age will be recorded to evaluate any association with MP change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sex</measure>
    <time_frame>Day 0</time_frame>
    <description>Sex will be recorded to evaluate any association with MP change</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of lesion at MRI</measure>
    <time_frame>Day 0</time_frame>
    <description>Type of lesion at MRI, according to Neonatal Neuroimaging Classification System (maldevelopments | predominant white matter injury | predominant grey matter injury | miscellaneous | Normal). Data will be registered based on previously acquired MRI, considering that the exam is mandatory for the diagnosis of cerebral palsy. It will be recorded to evaluate any association with MP change</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Quadriplegic Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>sitting position centering femoral heads</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sitting position centering femoral heads according to Lespargot diagram</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual postural management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>sitting with the trunk aligned and hips abducted to facilitate activities of daily living</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>postural management</intervention_name>
    <description>postural management in sitting position</description>
    <arm_group_label>Usual postural management</arm_group_label>
    <arm_group_label>sitting position centering femoral heads</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cerebral palsy spastic or dyskinetic&#xD;
&#xD;
          -  GMFCS 4 or 5&#xD;
&#xD;
          -  MP&lt;41%&#xD;
&#xD;
          -  Informed Consent acquired&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  muscle contracture overcoming defined passive Range Of Motion (ROM)limits&#xD;
&#xD;
          -  anterior hip luxation&#xD;
&#xD;
          -  previous reconstructive hip surgery&#xD;
&#xD;
          -  preventive surgery in previous 12 months&#xD;
&#xD;
          -  lumbar scoliosis &gt;20° Cobb&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SILVIA FACCIOLI</last_name>
    <role>Study Chair</role>
    <affiliation>Azienda Unità Sanitaria Locale Reggio Emilia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SILVIA FACCIOLI</last_name>
    <phone>+39 0522296208</phone>
    <email>silvia.faccioli@ausl.re.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Azienda Unità Sanitaria Locale Reggio Emilia</name>
      <address>
        <city>Reggio Emilia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>silvia faccioli</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Bouwhuis CB, van der Heijden-Maessen HC, Boldingh EJ, Bos CF, Lankhorst GJ. Effectiveness of preventive and corrective surgical intervention on hip disorders in severe cerebral palsy: a systematic review. Disabil Rehabil. 2015;37(2):97-105. doi: 10.3109/09638288.2014.908961. Epub 2014 Apr 14. Review.</citation>
    <PMID>24731007</PMID>
  </reference>
  <reference>
    <citation>Dalen Y, Saaf M, Ringertz H, Klefbeck B, Mattsson E, Haglund-Akerlind Y. Effects of standing on bone density and hip dislocation in children with severe cerebral palsy. Adv Physiother,2010;12:187-93.</citation>
  </reference>
  <reference>
    <citation>Diab M, Staheli LT. Ortopedia Pediatrica, 3° ed., Verduci ed., p.65</citation>
  </reference>
  <reference>
    <citation>Galeoto G, Colucci M, Guarino D, Esposito G, Cosma E, De Santis R, Grifoni G, Valente D, Tofani M. Exploring Validity, Reliability, and Factor Analysis of the Quebec User Evaluation of Satisfaction with Assistive Technology in an Italian Population: A Cross-Sectional Study. Occup Ther Health Care. 2018 Oct;32(4):380-392. doi: 10.1080/07380577.2018.1522682. Epub 2018 Dec 31.</citation>
    <PMID>30596451</PMID>
  </reference>
  <reference>
    <citation>Hägglund G, Goldring M, Hermanson M, Rodby-Bousquet E. Pelvic obliquity and measurement of hip displacement in children with cerebral palsy. Acta Orthop. 2018 Dec;89(6):652-655. doi: 10.1080/17453674.2018.1519104. Epub 2018 Oct 17.</citation>
    <PMID>30326758</PMID>
  </reference>
  <reference>
    <citation>Hägglund G, Lauge-Pedersen H, Wagner P. Characteristics of children with hip displacement in cerebral palsy. BMC Musculoskelet Disord. 2007 Oct 26;8:101.</citation>
    <PMID>17963501</PMID>
  </reference>
  <reference>
    <citation>• Lespargot A. La luxation postéro-externe de la hanche chez l'enfant IMC ou polyhandicapé. Motricité cérébrale,1991;12:37-61</citation>
  </reference>
  <reference>
    <citation>Lins LAB, Watkins CJ, Shore BJ. Natural History of Spastic Hip Disease. J Pediatr Orthop. 2019 Jul;39(Issue 6, Supplement 1 Suppl 1):S33-S37. doi: 10.1097/BPO.0000000000001347. Review.</citation>
    <PMID>31169645</PMID>
  </reference>
  <reference>
    <citation>Martinsson C, Himmelmann K. Effect of weight-bearing in abduction and extension on hip stability in children with cerebral palsy. Pediatr Phys Ther. 2011 Summer;23(2):150-7. doi: 10.1097/PEP.0b013e318218efc3.</citation>
    <PMID>21552077</PMID>
  </reference>
  <reference>
    <citation>Gmelig Meyling C, Ketelaar M, Kuijper MA, Voorman J, Buizer AI. Effects of Postural Management on Hip Migration in Children With Cerebral Palsy: A Systematic Review. Pediatr Phys Ther. 2018 Apr;30(2):82-91. doi: 10.1097/PEP.0000000000000488. Review.</citation>
    <PMID>29578990</PMID>
  </reference>
  <reference>
    <citation>Miller SD, Juricic M, Hesketh K, Mclean L, Magnuson S, Gasior S, Schaeffer E, O'donnell M, Mulpuri K. Prevention of hip displacement in children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2017 Nov;59(11):1130-1138. doi: 10.1111/dmcn.13480. Epub 2017 Jun 2. Review.</citation>
    <PMID>28574172</PMID>
  </reference>
  <reference>
    <citation>Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006 Oct;48(10):804-12.</citation>
    <PMID>16978459</PMID>
  </reference>
  <reference>
    <citation>Picciolini O, LE Métayer M, Consonni D, Cozzaglio M, Porro M, Gasparroni V, Panou A, Mosca F, Portinaro NM. Can we prevent hip dislocation in children with cerebral palsy? Effects of postural management. Eur J Phys Rehabil Med. 2016 Oct;52(5):682-690. Epub 2016 May 6.</citation>
    <PMID>27153480</PMID>
  </reference>
  <reference>
    <citation>Sproccati N, Bertana S, Battisti N, Feliciangeli A, Baroncini C, Zenesini C, Cersosimo A. Italian translation and cross-cultural adaptation of the questionnaire for the assessment of quality of life in children with cerebral palsy: caregiver priorities and child health index of life with disabilities. Minerva Med. 2019 Jun 25. doi: 10.23736/S0026-4806.19.06072-5. [Epub ahead of print]</citation>
    <PMID>31256575</PMID>
  </reference>
  <reference>
    <citation>Terjesen T. The natural history of hip development in cerebral palsy. Dev Med Child Neurol. 2012 Oct;54(10):951-7. doi: 10.1111/j.1469-8749.2012.04385.x. Epub 2012 Aug 13.</citation>
    <PMID>22881288</PMID>
  </reference>
  <reference>
    <citation>Wynter M, Gibson N, Willoughby KL, Love S, Kentish M, Thomason P, Graham HK; National Hip Surveillance Working Group. Australian hip surveillance guidelines for children with cerebral palsy: 5-year review. Dev Med Child Neurol. 2015 Sep;57(9):808-20. doi: 10.1111/dmcn.12754. Epub 2015 Apr 3. Review.</citation>
    <PMID>25846730</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 1, 2020</study_first_submitted>
  <study_first_submitted_qc>October 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>October 25, 2020</last_update_submitted>
  <last_update_submitted_qc>October 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hip luxation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Dislocations</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We are going to share results and data at the end of the study by publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

